Home
General Information to Patients
ALL
AML
Anus
Bladder/urothelial
Brain
Breast
Cervix
CLL
CML
Colon and Rectum
GIST
Hairy Cell Leuk.
Head and Neck
Hemato/Graft
Hepatic Ducts
Hodgkin
Kidney
Liver
Melanoma
Mesothelioma
MPN
MDS
Myeloma
Neuroendocr. T
NSCLC
NHL
Oesophagus
Ovary
Pancreas
Prostate
Sarcoma
Skin
SCLC
Solid Tumors
Stomach
Testis
Thyroid
Uterine Sarcoma
Uterus Lining
Clinical Trials
View all
Search
Videos for patients
Oral therapy
Chemo & Immunotherapy
Immunotherapy (professionals)
Guidelines : Management of Toxicities
Administration Guides and Advice to patients
Administrative Tools
Recherche
Home
Infos/documents - Immunotherapy
Guidelines : Management of Toxicities
Administration Guides and Advice to patients
Administrative Tools
IMMUNOTHERAPY
Guidelines : Management of Toxicities
ASCO - Management of Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Therapy (December 2021)
ESMO - Management of toxicities from immunotherapy (octobre 2022)
NCCN - Management of Immunotherapy-Related Toxicities ***connexion requise*** (October 2024)
Groupe d'étude en oncologie du Québec